The state of Wyoming currently has 2 active clinical trials seeking participants for Hypertension research studies. These trials are conducted in various cities, including Sheridan, Cody, Casper and Cheyenne.
Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity
Recruiting
A combination of generally regarded as safe (GRAS) compounds named GLY-LOW, which included: alpha lipoic acid, pyridoxamine, nicotinamide, piperine and thiamine, were examined in pre-clinical experiments. GLY-LOW supplementation reduced caloric intake and increased insulin sensitivity in mice. In female mice, GLY-LOW supplementation reversed aging-related declines in female hormones. Studies in humans are needed to examine the feasibility, utility and efficacy of GLY-LOW supplementation in post-... Read More
Gender:
Female
Ages:
56 years and above
Trial Updated:
01/29/2024
Locations: Hoskinson Health and Wellness Clinic, Gillette, Wyoming
Conditions: Insulin Resistance, Obesity, Cardiovascular Diseases, Cognitive Impairment, Physical Disability, Depression, Inflammation, Hormone Deficiency, Physical Inactivity, Hyperlipidemias, Hypertension, Overeating
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGANĀ® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Recruiting
This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonstrate bioequivalence with clinical endpoint in subjects with chronic open-angle glaucoma or ocular hypertension in both eyes. Test Product - Bimatoprost ophthalmic solution, 0.01% of Amneal EU, Limited Reference Product - LUMIGANĀ® (bimatoprost ophthalmic solution) 0.01% of Allergan, Inc.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/09/2022
Locations: Cheyenne Eye Clinic & Surgery Center, Cheyenne, Wyoming
Conditions: Glaucoma, Open-Angle, Ocular Hypertension